HIS
AXSM icon

Harvest Investment Services’s Axsome Therapeutics AXSM Stock Holding History

Harvest Investment Services’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-16,349
Closed -$1.17M – 146
2023
Q2 		$1.17M Buy
+16,349
New +$1.21M 0.67% 50
2022
Q4 		– Sell
-4,602
Closed -$205K – 120
2022
Q3 		$205K Buy
+4,602
New +$230K 0.25% 103

Other funds holding AXSM

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Harvest Investment Services's AXSM Position: Q3 2023 in Review

Harvest Investment Services sold out of Axsome Therapeutics (AXSM) in Q3 2023, closing a stake of 16,349 shares — an estimated $1.17M sold.

Harvest Investment Services first reported a position in AXSM in Q3 2022 and held it in 2 quarters. The position peaked at $1.17M in Q2 2023. 226 funds tracked by Wall St. Rank hold AXSM as of Q3 2023.

  • Harvest Investment Services reported no remaining Axsome Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Harvest Investment Services sold 16,349 Axsome Therapeutics shares in Q3 2023, an estimated $1.17M.
  • Harvest Investment Services first reported a position in Axsome Therapeutics in Q3 2022 and held it in 2 quarters.
  • Harvest Investment Services's Axsome Therapeutics position peaked at $1.17M in Q2 2023.
  • 226 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2023.

Based on Harvest Investment Services's 13F filing for Q3 2023, filed 14 Nov 2023.